世界のヒト絨毛性ゴナドトロピン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Chorionic Gonadotropin Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2941 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学、材料

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ヒト絨毛性ゴナドトロピンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（天然資源抽出、組換え技術）、用途別市場規模（不妊治療クリニック、研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒト絨毛性ゴナドトロピンの市場動向 ・企業の競争状況、市場シェア ・ヒト絨毛性ゴナドトロピンの種類別市場規模（天然資源抽出、組換え技術） ・ヒト絨毛性ゴナドトロピンの用途別市場規模（不妊治療クリニック、研究機関、その他） ・ヒト絨毛性ゴナドトロピンの北米市場規模2016-2027（アメリカ、カナダ） ・ヒト絨毛性ゴナドトロピンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト絨毛性ゴナドトロピンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト絨毛性ゴナドトロピンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト絨毛性ゴナドトロピンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol Myers Squibb、Merck & Co、Ferring、Fresenius Kabi、Sun Pharmaceutical） ・結論

Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.

Market Analysis and Insights: Global Human Chorionic Gonadotropin Market
The global Human Chorionic Gonadotropin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Chorionic Gonadotropin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Chorionic Gonadotropin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Chorionic Gonadotropin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Chorionic Gonadotropin market.

Global Human Chorionic Gonadotropin Scope and Market Size
Human Chorionic Gonadotropin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Chorionic Gonadotropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Natural Source Extraction
Recombinant Technology

Segment by Application
Fertility Clinics
Research Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol Myers Squibb
Merck & Co
Ferring
Fresenius Kabi
Sun Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Chorionic Gonadotropin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Natural Source Extraction
1.2.3 Recombinant Technology
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotropin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Fertility Clinics
1.3.3 Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Chorionic Gonadotropin Market Perspective (2016-2027)
2.2 Human Chorionic Gonadotropin Growth Trends by Regions
2.2.1 Human Chorionic Gonadotropin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Chorionic Gonadotropin Historic Market Share by Regions (2016-2021)
2.2.3 Human Chorionic Gonadotropin Forecasted Market Size by Regions (2022-2027)
2.3 Human Chorionic Gonadotropin Industry Dynamic
2.3.1 Human Chorionic Gonadotropin Market Trends
2.3.2 Human Chorionic Gonadotropin Market Drivers
2.3.3 Human Chorionic Gonadotropin Market Challenges
2.3.4 Human Chorionic Gonadotropin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Chorionic Gonadotropin Players by Revenue
3.1.1 Global Top Human Chorionic Gonadotropin Players by Revenue (2016-2021)
3.1.2 Global Human Chorionic Gonadotropin Revenue Market Share by Players (2016-2021)
3.2 Global Human Chorionic Gonadotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Chorionic Gonadotropin Revenue
3.4 Global Human Chorionic Gonadotropin Market Concentration Ratio
3.4.1 Global Human Chorionic Gonadotropin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotropin Revenue in 2020
3.5 Human Chorionic Gonadotropin Key Players Head office and Area Served
3.6 Key Players Human Chorionic Gonadotropin Product Solution and Service
3.7 Date of Enter into Human Chorionic Gonadotropin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Chorionic Gonadotropin Breakdown Data by Type
4.1 Global Human Chorionic Gonadotropin Historic Market Size by Type (2016-2021)
4.2 Global Human Chorionic Gonadotropin Forecasted Market Size by Type (2022-2027)

5 Human Chorionic Gonadotropin Breakdown Data by Application
5.1 Global Human Chorionic Gonadotropin Historic Market Size by Application (2016-2021)
5.2 Global Human Chorionic Gonadotropin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Chorionic Gonadotropin Market Size (2016-2027)
6.2 North America Human Chorionic Gonadotropin Market Size by Type
6.2.1 North America Human Chorionic Gonadotropin Market Size by Type (2016-2021)
6.2.2 North America Human Chorionic Gonadotropin Market Size by Type (2022-2027)
6.2.3 North America Human Chorionic Gonadotropin Market Size by Type (2016-2027)
6.3 North America Human Chorionic Gonadotropin Market Size by Application
6.3.1 North America Human Chorionic Gonadotropin Market Size by Application (2016-2021)
6.3.2 North America Human Chorionic Gonadotropin Market Size by Application (2022-2027)
6.3.3 North America Human Chorionic Gonadotropin Market Size by Application (2016-2027)
6.4 North America Human Chorionic Gonadotropin Market Size by Country
6.4.1 North America Human Chorionic Gonadotropin Market Size by Country (2016-2021)
6.4.2 North America Human Chorionic Gonadotropin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Human Chorionic Gonadotropin Market Size (2016-2027)
7.2 Europe Human Chorionic Gonadotropin Market Size by Type
7.2.1 Europe Human Chorionic Gonadotropin Market Size by Type (2016-2021)
7.2.2 Europe Human Chorionic Gonadotropin Market Size by Type (2022-2027)
7.2.3 Europe Human Chorionic Gonadotropin Market Size by Type (2016-2027)
7.3 Europe Human Chorionic Gonadotropin Market Size by Application
7.3.1 Europe Human Chorionic Gonadotropin Market Size by Application (2016-2021)
7.3.2 Europe Human Chorionic Gonadotropin Market Size by Application (2022-2027)
7.3.3 Europe Human Chorionic Gonadotropin Market Size by Application (2016-2027)
7.4 Europe Human Chorionic Gonadotropin Market Size by Country
7.4.1 Europe Human Chorionic Gonadotropin Market Size by Country (2016-2021)
7.4.2 Europe Human Chorionic Gonadotropin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotropin Market Size (2016-2027)
8.2 Asia-Pacific Human Chorionic Gonadotropin Market Size by Type
8.2.1 Asia-Pacific Human Chorionic Gonadotropin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Chorionic Gonadotropin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Chorionic Gonadotropin Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Chorionic Gonadotropin Market Size by Application
8.3.1 Asia-Pacific Human Chorionic Gonadotropin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Chorionic Gonadotropin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Chorionic Gonadotropin Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region
8.4.1 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Chorionic Gonadotropin Market Size (2016-2027)
9.2 Latin America Human Chorionic Gonadotropin Market Size by Type
9.2.1 Latin America Human Chorionic Gonadotropin Market Size by Type (2016-2021)
9.2.2 Latin America Human Chorionic Gonadotropin Market Size by Type (2022-2027)
9.2.3 Latin America Human Chorionic Gonadotropin Market Size by Type (2016-2027)
9.3 Latin America Human Chorionic Gonadotropin Market Size by Application
9.3.1 Latin America Human Chorionic Gonadotropin Market Size by Application (2016-2021)
9.3.2 Latin America Human Chorionic Gonadotropin Market Size by Application (2022-2027)
9.3.3 Latin America Human Chorionic Gonadotropin Market Size by Application (2016-2027)
9.4 Latin America Human Chorionic Gonadotropin Market Size by Country
9.4.1 Latin America Human Chorionic Gonadotropin Market Size by Country (2016-2021)
9.4.2 Latin America Human Chorionic Gonadotropin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotropin Market Size (2016-2027)
10.2 Middle East & Africa Human Chorionic Gonadotropin Market Size by Type
10.2.1 Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Application
10.3.1 Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country
10.4.1 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Introduction
11.1.4 Bristol Myers Squibb Revenue in Human Chorionic Gonadotropin Business (2016-2021)
11.1.5 Bristol Myers Squibb Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Human Chorionic Gonadotropin Introduction
11.2.4 Merck & Co Revenue in Human Chorionic Gonadotropin Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Human Chorionic Gonadotropin Introduction
11.3.4 Ferring Revenue in Human Chorionic Gonadotropin Business (2016-2021)
11.3.5 Ferring Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Details
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Human Chorionic Gonadotropin Introduction
11.4.4 Fresenius Kabi Revenue in Human Chorionic Gonadotropin Business (2016-2021)
11.4.5 Fresenius Kabi Recent Development
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Details
11.5.2 Sun Pharmaceutical Business Overview
11.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Introduction
11.5.4 Sun Pharmaceutical Revenue in Human Chorionic Gonadotropin Business (2016-2021)
11.5.5 Sun Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Chorionic Gonadotropin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Natural Source Extraction
Table 3. Key Players of Recombinant Technology
Table 4. Global Human Chorionic Gonadotropin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human Chorionic Gonadotropin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Chorionic Gonadotropin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human Chorionic Gonadotropin Market Share by Regions (2016-2021)
Table 8. Global Human Chorionic Gonadotropin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human Chorionic Gonadotropin Market Share by Regions (2022-2027)
Table 10. Human Chorionic Gonadotropin Market Trends
Table 11. Human Chorionic Gonadotropin Market Drivers
Table 12. Human Chorionic Gonadotropin Market Challenges
Table 13. Human Chorionic Gonadotropin Market Restraints
Table 14. Global Human Chorionic Gonadotropin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human Chorionic Gonadotropin Market Share by Players (2016-2021)
Table 16. Global Top Human Chorionic Gonadotropin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Chorionic Gonadotropin as of 2020)
Table 17. Ranking of Global Top Human Chorionic Gonadotropin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human Chorionic Gonadotropin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Chorionic Gonadotropin Product Solution and Service
Table 21. Date of Enter into Human Chorionic Gonadotropin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Chorionic Gonadotropin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human Chorionic Gonadotropin Revenue Market Share by Type (2016-2021)
Table 25. Global Human Chorionic Gonadotropin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human Chorionic Gonadotropin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human Chorionic Gonadotropin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human Chorionic Gonadotropin Revenue Market Share by Application (2016-2021)
Table 29. Global Human Chorionic Gonadotropin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human Chorionic Gonadotropin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human Chorionic Gonadotropin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human Chorionic Gonadotropin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human Chorionic Gonadotropin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human Chorionic Gonadotropin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human Chorionic Gonadotropin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human Chorionic Gonadotropin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human Chorionic Gonadotropin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human Chorionic Gonadotropin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human Chorionic Gonadotropin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human Chorionic Gonadotropin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human Chorionic Gonadotropin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human Chorionic Gonadotropin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human Chorionic Gonadotropin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human Chorionic Gonadotropin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Chorionic Gonadotropin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Chorionic Gonadotropin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human Chorionic Gonadotropin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human Chorionic Gonadotropin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human Chorionic Gonadotropin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human Chorionic Gonadotropin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human Chorionic Gonadotropin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human Chorionic Gonadotropin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bristol Myers Squibb Company Details
Table 62. Bristol Myers Squibb Business Overview
Table 63. Bristol Myers Squibb Human Chorionic Gonadotropin Product
Table 64. Bristol Myers Squibb Revenue in Human Chorionic Gonadotropin Business (2016-2021) & (US$ Million)
Table 65. Bristol Myers Squibb Recent Development
Table 66. Merck & Co Company Details
Table 67. Merck & Co Business Overview
Table 68. Merck & Co Human Chorionic Gonadotropin Product
Table 69. Merck & Co Revenue in Human Chorionic Gonadotropin Business (2016-2021) & (US$ Million)
Table 70. Merck & Co Recent Development
Table 71. Ferring Company Details
Table 72. Ferring Business Overview
Table 73. Ferring Human Chorionic Gonadotropin Product
Table 74. Ferring Revenue in Human Chorionic Gonadotropin Business (2016-2021) & (US$ Million)
Table 75. Ferring Recent Development
Table 76. Fresenius Kabi Company Details
Table 77. Fresenius Kabi Business Overview
Table 78. Fresenius Kabi Human Chorionic Gonadotropin Product
Table 79. Fresenius Kabi Revenue in Human Chorionic Gonadotropin Business (2016-2021) & (US$ Million)
Table 80. Fresenius Kabi Recent Development
Table 81. Sun Pharmaceutical Company Details
Table 82. Sun Pharmaceutical Business Overview
Table 83. Sun Pharmaceutical Human Chorionic Gonadotropin Product
Table 84. Sun Pharmaceutical Revenue in Human Chorionic Gonadotropin Business (2016-2021) & (US$ Million)
Table 85. Sun Pharmaceutical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Chorionic Gonadotropin Market Share by Type: 2020 VS 2027
Figure 2. Natural Source Extraction Features
Figure 3. Recombinant Technology Features
Figure 4. Global Human Chorionic Gonadotropin Market Share by Application: 2020 VS 2027
Figure 5. Fertility Clinics Case Studies
Figure 6. Research Institutions Case Studies
Figure 7. Others Case Studies
Figure 8. Human Chorionic Gonadotropin Report Years Considered
Figure 9. Global Human Chorionic Gonadotropin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Human Chorionic Gonadotropin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Chorionic Gonadotropin Market Share by Regions: 2020 VS 2027
Figure 12. Global Human Chorionic Gonadotropin Market Share by Regions (2022-2027)
Figure 13. Global Human Chorionic Gonadotropin Market Share by Players in 2020
Figure 14. Global Top Human Chorionic Gonadotropin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Chorionic Gonadotropin as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Human Chorionic Gonadotropin Revenue in 2020
Figure 16. Global Human Chorionic Gonadotropin Revenue Market Share by Type (2016-2021)
Figure 17. Global Human Chorionic Gonadotropin Revenue Market Share by Type (2022-2027)
Figure 18. North America Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Human Chorionic Gonadotropin Market Share by Type (2016-2027)
Figure 20. North America Human Chorionic Gonadotropin Market Share by Application (2016-2027)
Figure 21. North America Human Chorionic Gonadotropin Market Share by Country (2016-2027)
Figure 22. United States Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human Chorionic Gonadotropin Market Share by Type (2016-2027)
Figure 26. Europe Human Chorionic Gonadotropin Market Share by Application (2016-2027)
Figure 27. Europe Human Chorionic Gonadotropin Market Share by Country (2016-2027)
Figure 28. Germany Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human Chorionic Gonadotropin Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Human Chorionic Gonadotropin Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Human Chorionic Gonadotropin Market Share by Region (2016-2027)
Figure 38. China Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human Chorionic Gonadotropin Market Share by Type (2016-2027)
Figure 46. Latin America Human Chorionic Gonadotropin Market Share by Application (2016-2027)
Figure 47. Latin America Human Chorionic Gonadotropin Market Share by Country (2016-2027)
Figure 48. Mexico Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human Chorionic Gonadotropin Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Human Chorionic Gonadotropin Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Human Chorionic Gonadotropin Market Share by Country (2016-2027)
Figure 54. Turkey Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Human Chorionic Gonadotropin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in Human Chorionic Gonadotropin Business (2016-2021)
Figure 58. Merck & Co Revenue Growth Rate in Human Chorionic Gonadotropin Business (2016-2021)
Figure 59. Ferring Revenue Growth Rate in Human Chorionic Gonadotropin Business (2016-2021)
Figure 60. Fresenius Kabi Revenue Growth Rate in Human Chorionic Gonadotropin Business (2016-2021)
Figure 61. Sun Pharmaceutical Revenue Growth Rate in Human Chorionic Gonadotropin Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---